Lumigan and Hypoacusis - a phase IV clinical study of FDA data

Summary:

Hypoacusis is reported as a side effect among people who take Lumigan (bimatoprost), especially for people who are female, 60+ old, have been taking the drug for 6 - 12 months also take Cosopt, and have Arthritis.

The phase IV clinical study analyzes which people have Hypoacusis when taking Lumigan. It is created by eHealthMe based on reports of 20,141 people who have side effects when taking Lumigan from the FDA, and is updated regularly.

What is Lumigan?

Lumigan has active ingredients of bimatoprost. It is often used in glaucoma. eHealthMe is studying from 20,478 Lumigan users. Check the latest studies of Lumigan.

What is Hypoacusis?

Hypoacusis (loss of hearing) is found to be associated with 1,339 drugs and 1,184 conditions by eHealthMe. Check the latest studies of Hypoacusis.

On Jul, 03, 2026

20,141 people reported to have side effects when taking Lumigan.
Among them, 53 people (0.26%) have Hypoacusis.

Among these 53 people:

How long have people been on Lumigan when they have Hypoacusis? *

What is the gender of people who have Hypoacusis when taking Lumigan? *

female: 73.58 %
male: 26.42 %

What is the age of people who have Hypoacusis when taking Lumigan? *

What are other drugs people take besides Lumigan? *

What are other side effects people have besides Hypoacusis? *

Visual Acuity Reduced (reduced clearness of vision): 10 people, 18.87%
Vision Blurred: 6 people, 11.32%
Malaise (a feeling of general discomfort or uneasiness): 6 people, 11.32%
Dizziness: 5 people, 9.43%
Intraocular Pressure Increased: 5 people, 9.43%
Fall: 4 people, 7.55%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 4 people, 7.55%
Drug Ineffective: 4 people, 7.55%
Pain: 4 people, 7.55%
Visual Impairment: 4 people, 7.55%

What are the existing conditions these people have? *

Arthritis (form of joint disorder that involves inflammation of one or more joints): 4 people, 7.55%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 3 people, 5.66%
High Blood Cholesterol: 3 people, 5.66%
Multiple Myeloma (cancer of the plasma cells): 3 people, 5.66%
Nausea (feeling of having an urge to vomit): 3 people, 5.66%
Pain: 3 people, 5.66%
Intraocular Pressure Increased: 3 people, 5.66%
Diabetes: 2 people, 3.77%
Cardiac Disorder: 2 people, 3.77%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 3.77%

* Approximation only. Some reports may have incomplete information.

Do you take Lumigan and have Hypoacusis?

- Check whether Hypoacusis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lumigan:

Lumigan (20,478 reports)

Hypoacusis treatments and more:

Hypoacusis (48,633 reports)

Browse all side effects of Lumigan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypoacusis:

Hypoacusis (1,339 drugs)

Browse all the conditions that are associated with Hypoacusis:

Hypoacusis (1,184 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on bimatoprost (the active ingredients of Lumigan) and Lumigan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.